Navidea Biopharmaceuticals, Inc.
NAVBDelisted Jan 16, 2024- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000810509
Navidea Biopharmaceuticals, Inc. was delisted on Jan 16, 2024; its insiders filed their last Form 4 on Dec 5, 2023; 24 institutions reported holding it in 13F filings for Q3 2023, worth $225.8K in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Navidea Biopharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −2 vs. Q2 2021
- Shares held
- 1.58M
- −108.6K (−6.4%) vs. Q2 2021
- Total value
- $2.76M
- −$323.0K (−10.5%) vs. Q2 2021
- New holders
- 1
- 6 more added
- Sold out
- 3
- 9 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NAVB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 2 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 2 | $0 |
| Q1 2024 | 2 | $13 |
| Q4 2023 | 4 | $469 |
| Q3 2023 | 24 | $225.8K |
| Q2 2023 | 23 | $138.5K |
| Q1 2023 | 30 | $364.4K |
| Q4 2022 | 28 | $339.3K |
| Q3 2022 | 25 | $379.6K |
| Q2 2022 | 26 | $1.08M |
| Q1 2022 | 25 | $1.19M |
| Q4 2021 | 31 | $1.68M |
| Q3 2021 | 29 | $2.76M |
| Q2 2021 | 31 | $3.08M |
| Q1 2021 | 35 | $3.77M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Navidea Biopharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 738,361 | $1.29M | 0.00% | +8,600+1.2% | Added |
| BlackRock Inc. | 170,823 | $299.0K | 0.00% | −965−0.6% | Reduced |
| Bridgeway Capital Management, LLC | 102,440 | $179.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 97,100 | $170.0K | 0.00% | −56,186−36.7% | Reduced |
| Geode Capital Management, LLC | 97,206 | $170.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 67,779 | $119.0K | 0.00% | −35,542−34.4% | Reduced |
| Allred Capital Management, LLC | 64,988 | $114.0K | 0.06% | −8,800−11.9% | Reduced |
| Susquehanna International Group, LLP | 43,445 | $76.0K | 0.00% | +1,513+3.6% | Added |
| Citadel Advisors LLC | 42,137 | $74.0K | 0.00% | −22,506−34.8% | Reduced |
| Northern Trust Corp | 39,414 | $69.0K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 28,465 | $48.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 23,843 | $42.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 13,179 | $23.0K | 0.00% | 00.0% | Unchanged |
| Pathstone Family Office, LLC | 10,050 | $17.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 9,687 | $17.0K | 0.00% | +8,998+1,306.0% | Added |
| Tower Research Capital LLC (TRC) | 6,394 | $11.0K | 0.00% | +6,394 | New |
| UBS Group AG | 5,298 | $9.00K | 0.00% | −1,512−22.2% | Reduced |
| Wells Fargo & Company | 4,986 | $8.00K | 0.00% | +12+0.2% | Added |
| Morgan Stanley | 2,816 | $5.00K | 0.00% | −8,567−75.3% | Reduced |
| Advisor Group Holdings, Inc. | 2,150 | $4.00K | 0.00% | +2,000+1,333.3% | Added |
| Bank of America Corp | 1,822 | $3.00K | 0.00% | −7−0.4% | Reduced |
| JPMorgan Chase & Co | 1,050 | $2.00K | 0.00% | 00.0% | Unchanged |
| Jacobi Capital Management LLC | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 350 | $1.00K | 0.00% | 00.0% | Unchanged |
| Sound Income Strategies, LLC | 599 | $1.00K | 0.00% | 00.0% | Unchanged |
| Kelly Financial Services LLC | 50 | $88 | 0.00% | −42−45.7% | Reduced |
| Captrust Financial Advisors | 154 | $0 | 0.00% | +150+3,750.0% | Added |
| Simon Quick Advisors, LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 50 | – | – | 00.0% | Unchanged |
| Citigroup Inc | 0 | $0 | 0.00% | −1,912−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Center for Financial Planning, Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |